SCHEMBL7147034

SCHEMBL7147034

CCOC(=O)/C=C/Cc1ccc2c(c1)N(COC)c1nccnc1S2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 3/20 0.38
F13A1 P00488 1/20 0.34
TGM2 P21980 1/20 0.34
TGM1 P22735 1/20 0.34
TBXAS1 P24557 1/20 0.31
MAPT P10636 4/20 0.31
HSD17B10 Q99714 3/20 0.31
CSNK1E P49674 3/20 0.31
CLK1 P49759 3/20 0.31
CLK3 P49761 3/20 0.31
DYRK1A Q13627 3/20 0.31
DYRK1B Q9Y463 3/20 0.31
LMNA P02545 3/20 0.31
HTT P42858 3/20 0.31
ALDH1A1 P00352 3/20 0.31
PIM1 P11309 2/20 0.31
CSNK1D P48730 2/20 0.31
CSNK1G2 P78368 2/20 0.31
MAP3K19 Q56UN5 2/20 0.31
PIM3 Q86V86 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6749766 0.89 HDAC6 (0.40) HDAC6MAPTHSD17B10CSNK1ECLK1
SCHEMBL6749761 0.89 HDAC6 (0.40) HDAC6MAPTHSD17B10CSNK1ECLK1
SCHEMBL6751888 0.84 ICAM1 (0.43) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL6751892 0.84 ICAM1 (0.43) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL6751926 0.84 HDAC6 (0.38) HDAC6
SCHEMBL6747458 0.83 HDAC6 (0.40) HDAC6MAPTHSD17B10CSNK1ECLK1
SCHEMBL6747374 0.82 CYP4F2 (0.39) HDAC6
SCHEMBL7147037 0.80 HDAC6 (0.38) HDAC6MAPTHSD17B10CSNK1ECLK1
SCHEMBL6745730 0.79 HDAC6 (0.43) HDAC6MAPTHSD17B10ALDH1A1MEN1
SCHEMBL6749064 0.79 HDAC6 (0.41) HDAC6HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed